Gene expression profiling reveals potential key pathways involved in pyrazinamide-mediated hepatotoxicity in Wistar rats
Author:
Affiliation:
1. Jiangsu Center of Drug Screening; China Pharmaceutical University; 24 Tong Jia Xiang; Nanjing; 210009; China
2. The School of Pharmaceutical Engineering and Life Sciences; Changzhou University; Changzhou; 213000; China
Publisher
Wiley
Subject
Toxicology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jat.2736/fullpdf
Reference54 articles.
1. Antioxidative activity of persimmon and grape seed extract: in vitro and in vivo;Ahn;Nutr. Res.,2002
2. Ligand-induced expression of peroxisome proliferator-activated receptor α and activation of fatty acid oxidation enzymes in fatty liver;Akbiyik;Eur. J. Clin. Invest.,2004
3. Update: fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations - United States, 2001;American Thoracic Society/CDC;Morbid. Mortal. Wkly Rep.,2001
4. Drug-induced liver injury: insights from genetic studies;Andrade;Pharmacogenomics,2009
5. Isoniazid- and rifampicin-induced oxidative hepatic injury-protection by N-acetylcysteine;Attri;Hum. Exp. Toxicol.,2000
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Progress in Research on Hepatic Injury Caused by Anti-Tuberculosis Drugs;Advances in Clinical Medicine;2024
2. Hepatotoxic Components Effect of Chebulae Fructus and Associated Molecular Mechanism by Integrated Transcriptome and Molecular Docking;Molecules;2023-04-13
3. Mechanism of hydroxysafflor yellow A on acute liver injury based on transcriptomics;Frontiers in Pharmacology;2022-09-02
4. Metabolism and Hepatotoxicity of Pyrazinamide, an Antituberculosis Drug;Drug Metabolism and Disposition;2021-06-01
5. Association of POR and PPARα polymorphisms with risk of anti-tuberculosis drug-induced liver injury in Western Chinese Han population;Infection, Genetics and Evolution;2020-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3